RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will make three presentations of clinical and pre-clinical data regarding its PMX-30063 defensin-mimetic antibiotic compound at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The conference, held on behalf of the American Society for Microbiology (ASM) and the Infectious Diseases Society of America (IDSA), will be held in San Francisco, CA, Saturday, September 12 through Tuesday, September 15, 2009.
